MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹333 Cr | ₹241 Cr | ₹290 Cr | ₹167 Cr | ₹138 Cr |
What is the latest Total Current Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹333 Cr |
| Mar2024 | ₹241 Cr |
| Mar2023 | ₹290 Cr |
| Mar2022 | ₹167 Cr |
| Mar2021 | ₹138 Cr |
How is Total Current Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹333 Cr | 38.03 | |
| Mar2024 | ₹241 Cr | -16.89 | |
| Mar2023 | ₹290 Cr | 74.27 | |
| Mar2022 | ₹167 Cr | 20.76 | |
| Mar2021 | ₹138 Cr | - | |
Compare Total Current Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹380.4 Cr | -5.9% | -0.9% | -16.3% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹9,805.1 Cr | -5.3% | -25% | -24.9% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,270.7 Cr | -0.5% | -2.9% | -41.9% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,715.8 Cr | -4.1% | -14% | -29.2% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹764.4 Cr | -20.6% | -32.5% | -46.6% | Stock Analytics | |
| INDO US BIOTECH | ₹206.7 Cr | -3.5% | -28.3% | -39.2% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | -5.9% |
-0.9% |
-16.3% |
| SENSEX | 0.6% |
-11.1% |
-6.2% |
You may also like the below Video Courses